Increased immunogenicity of human renal carcinoma cells following treatment with cholesterol derivatives.
Tumor cells isolated from human renal cell carcinoma biopsies were treated with cholesteryl hemisuccinate or 25-hydroxycholesterol and the subsequent changes in their membrane fluidity and capacity to induce skin reactivity in the homologous patient were investigated. Both cholesterol derivatives were found equally efficient in decreasing membrane fluidity when measured by fluorescence polarization of diphenylhexatriene. Using trimethylammonium-diphenylhexatriene, a specific cell surface probe, 25-hydroxycholesterol, appeared much more efficient than cholesteryl hemisuccinate in inducing a membrane rigidification in the carcinoma cells. Cells treated with cholesteryl hemisuccinate induced a strong positive skin reaction compatible with delayed-type hypersensitivity in 54% of the patients, whereas 25-hydroxycholesterol-treated cells were less potent (36% positive skin reactions). Thus, manipulation of the physicochemical state of the membrane of human renal carcinoma cells could increase their immunogenicity in the autologous patient, although this seemed not to be related only to membrane rigidification.
Ludes
B
B
Institut d'Hématologie et d'Immunologie, Hôpital Civil, Strasbourg, France.
Staedel
C
C
Jacqmin
D
D
Cremel
G
G
Hubert
P
P
Bollack
C
C
Beck
J P
JP
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000276:immunology*; D002788:Cholesterol Esters / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006888:Hydroxycholesterols / Q000494:pharmacology*; D007680:Kidney Neoplasms / Q000276:immunology*; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects*; D008875:Middle Aged; D012882:Skin Tests; D014407:Tumor Cells, Cultured / Q000187:drug effects
D002788:Cholesterol Esters; D006888:Hydroxycholesterols; C007997:25-hydroxycholesterol; C013440:cholesteryl succinate